Impact of Coronary Computed Tomographic Angiography Findings on the Medical Treatment and Control of Coronary Artery Disease and Its Risk Factors††Conflicts of interest: Dr. Min has a research grant from GE Healthcare, Milwaukee, Wisconsin; is on the speaker's bureau for GE Healthcare; has a research grant from Vital Images, Minnetonka, Minnesota; and is a consultant for the Cordis Corporation, Miami Lakes, Florida. Dr. Devereux is a consultant for Merck & Company, Whitehouse Station, New Jersey; Novartis AG, Basel, Switzerland; Sanofi-Aventis, Paris, France; and Novo Nordisk A/S, Bagsværd, Denmark.

Title

Impact of Coronary Computed Tomographic Angiography Findings on the Medical Treatment and Control of Coronary Artery Disease and Its Risk Factors††Conflicts of interest: Dr. Min has a research grant from GE Healthcare, Milwaukee, Wisconsin; is on the speaker's bureau for GE Healthcare; has a research grant from Vital Images, Minnetonka, Minnesota; and is a consultant for the Cordis Corporation, Miami Lakes, Florida. Dr. Devereux is a consultant for Merck & Company, Whitehouse Station, New Jersey; Novartis AG, Basel, Switzerland; Sanofi-Aventis, Paris, France; and Novo Nordisk A/S, Bagsværd, Denmark.

Authors

Keywords

-

Journal

AMERICAN JOURNAL OF CARDIOLOGY

Volume 104, Issue 7, Pages 873-877

Publisher

Elsevier BV

Online

2009-09-19

DOI

10.1016/j.amjcard.2009.05.024